National Welfare & Human Development Org (NWHDO)

Email

nwhdo001@gmail.com

Phone

T + 92 223895038

Web

www.nwhdo.org.pk

Address

Near Uderolal bus stop Nassrpur, District Tando Allahyar, Sindh 70040 70040 Pakistan
About National Welfare & Human Development Org (NWHDO)

The National Welfare and Human Development Organization (NWHDO) is non-political and non-profit organization established and registered in District Matiari in 2009 under the Voluntary Social Welfare Agencies (Reg. &control) Ordinance 1961. Subsequently the Union Council Nasarpur was excluded from district Matiari and included in district tando Allahyar, by the Government.

The National Welfare and Human Development Organization is a newly established registered organization, with its base office at Nasarpur town, taluka and district Tando Allahyar, Sindh Pakistan. The idea for establishing NWHDO is a result of long consultative process, and solicitous thought given to famishing human development conditions, which reflect the comparative status of sustainable economic development , and leave an adverse impact on overall progressive status of the masses. Several visits to rural communities postured a dismal picture, main cause being the poverty and backwardness. There was a sense of deprivation in these communities, as they were living in dehumanizing conditions. They wanted a respectable living standard, with every facility at their door steps.

Subsequently the entirety of situation was contemplated and deliberated . Some matured and senior citizens, activists, intellectuals, and youngsters, decided to establish an organization, for welfare and development of civil society, specially the neglected areas making start from district Matiari. Reason for limiting geographical focus to only one district, was to gain experience and then to enhance the area of operation to provincial level, and across the country.

NWHDO hopes that in due course of time it will be an organization of international repute and excellence, and hallmark for service to civil society. Our focus will be to achieve in 21th century, what we could not gain in 20th century.

Vision

A society free of de-humanizing conditions with better education, sound health, less poverty, healthy environment and access to other basic needs

Mission

To deliver services for national welfare and sustainable human development to less privileged rural, semi urban and less privileged areas under the themes of NWHDO. 

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close